The Hippo Tumor Suppressor Pathway: A Brainstorming Workshop
Giovanni Blandino1,
Yosef Shaul2,
Sabrina Strano1,
Marius Sudol3,4*, and
Michael Yaffe5
1 Department of Molecular Medicine, Regina Elena Cancer Institute, Rome 00144, Italy.
2 Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel.
3 Laboratory of Signal Transduction and Proteomic Profiling, Weis Center for Research, Geisinger Clinic, Danville, PA 17822, USA.
4 Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA.
5 Koch Institute for Integrative Cancer Biology, Massachusetts Institute of Technology, Boston, MA 02139, USA.
A report on the research meeting "The Hippo Tumor Suppressor Pathway: A Brainstorming Workshop" sponsored mainly by the Regina Elena Cancer Center and the Nicola Foundation and held in Rome, Italy, on 22 and 23 April 2009.
Abstract:
Researchers from around the world met for two days in April this year in Rome, Italy, to discuss progress in the rapidly developing field of Hippo signaling, which is relevant to cancer and the control of organ size. Most of the participants presented data related to previously uncharacterized proteins that physically and functionally interact with known components of the Hippo pathway and regulate its biological output.
* Corresponding author. E-mail: msudol1{at}geisinger.edu
